Literature DB >> 24757305

Anticancer Effect of dl-Glyceraldehyde and 2-Deoxyglucose in Ehrlich Ascites Carcinoma Bearing Mice and Their Effect on Liver, Kidney and Haematological Parameters.

R Kapoor1, D B Gundpatil1, B L Somani1, T K Saha1, S Bandyopadhyay2, P Misra1.   

Abstract

Cancer cells generally exhibit increased glycolysis for ATP generation (the Warburg effect). Compounds that inhibit glycolysis have potential applications in cancer treatment. dl-glyceraldehyde (DLG) and 2-Deoxyglucose (2-DG) have been proven effective in the inhibition of glucose metabolism. Ehrlich ascites carcinoma (EAC) cells were injected intraperitoneally (i.p) in 10-12 weeks old Swiss albino mice, weighing between 20 and 30 g. The anticancer activity of DLG and 2-DG were determined by tumor volume, tumor weight, viable and nonviable tumor cell count, average survival time, percentage increase in life span and tumor inhibition ratio. The blood samples were obtained for biochemical analysis after 9 days of treatment to study the effect on liver, kidney and haematological parameters. Histopathological examination of liver and kidney was also performed. One-way ANOVA test and Dunnett's test were used for comparisons of parameters in study groups. Both DLG and 2-DG individually decreased the tumor weight, tumor volume, viable tumor cell count and significantly increased the life span of treated mice, however the combination was found to be better. The biochemical parameters of liver and kidney functions and haematological parameters were restored close to control group as compared with the EAC bearing mice. Histopathological examination of liver and kidney in EAC control group showed large areas of necrosis, congestion and mononuclear cell infiltration but such changes were not observed in liver and kidney sections observed after i.p injection of DLG and 2-DG for 9 days. Improvement was much better in the group where combination of these two drugs were used.

Entities:  

Keywords:  2-Deoxyglucose; Anticancer; Ehrlich ascites carcinoma; Glycolysis; dl-Glyceraldehyde

Year:  2013        PMID: 24757305      PMCID: PMC3990809          DOI: 10.1007/s12291-013-0343-y

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  20 in total

1.  Effects of glucose analogues (2-deoxy-D-glucose, 2-deoxy-D-galactose) on experimental tumors.

Authors:  J LASZLO; S R HUMPHREYS; A GOLDIN
Journal:  J Natl Cancer Inst       Date:  1960-02       Impact factor: 13.506

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in ehrlich ascites tumor-bearing mice.

Authors:  Seema Gupta; Rohit Mathur; B S Dwarakanath
Journal:  Cancer Biol Ther       Date:  2005-01-15       Impact factor: 4.742

4.  Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy.

Authors:  G S Karczmar; J M Arbeit; B J Toy; A Speder; M W Weiner
Journal:  Cancer Res       Date:  1992-01-01       Impact factor: 12.701

5.  Energy linked modifications of the radiation response in a human cerebral glioma cell line.

Authors:  B S Dwarkanath; V K Jain
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-11       Impact factor: 7.038

6.  Fructose 2,6-bisphosphate and the control of glycolysis by glucocorticoids and by other agents in rat hepatoma cells.

Authors:  A M Loiseau; G G Rousseau; L Hue
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

7.  Inhibition of mouse ascites tumors by carbohydrate combined with immunization.

Authors:  C P Eng; M K Bhatnagar; J F Morgan
Journal:  Can J Physiol Pharmacol       Date:  1972-02       Impact factor: 2.273

8.  Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.

Authors:  M C Bissery; D Guénard; F Guéritte-Voegelein; F Lavelle
Journal:  Cancer Res       Date:  1991-09-15       Impact factor: 12.701

Review 9.  Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors.

Authors:  Seema Gupta; Abdullah Farooque; J S Adhikari; Saurabh Singh; B S Dwarakanath
Journal:  J Cancer Res Ther       Date:  2009-09       Impact factor: 1.805

10.  Antitumor Activity of Citrus maxima (Burm.) Merr. Leaves in Ehrlich's Ascites Carcinoma Cell-Treated Mice.

Authors:  Sriparna Kundusen; Malaya Gupta; Upal K Mazumder; Pallab K Haldar; Prerona Saha; Asis Bala
Journal:  ISRN Pharmacol       Date:  2011-04-19
View more
  4 in total

1.  Influence of halloysite nanotubes on the efficiency of Asparaginase against mice Ehrlich solid carcinoma.

Authors:  B M M Baharoon; A M Shaik; Salim M El-Hamidy; Rady Eid El-Araby; Ashwaq H Batawi; Mohamed Abdel Salam
Journal:  Saudi J Biol Sci       Date:  2022-03-04       Impact factor: 4.052

2.  Effect of Theobroma cacao L. on the Efficacy and Toxicity of Doxorubicin in Mice Bearing Ehrlich Ascites Carcinoma.

Authors:  Priyanka P Patil; Pukar Khanal; Vishal S Patil; Rajitha Charla; Darasaguppe R Harish; Basanagouda M Patil; Subarna Roy
Journal:  Antioxidants (Basel)       Date:  2022-05-31

3.  Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach.

Authors:  Maged Kharouba; Amal El-Kamel; Radwa Mehanna; Eman Thabet; Lamia Heikal
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

4.  Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy.

Authors:  Sneha Mishra; Ankit Kumar Tamta; Mohsen Sarikhani; Perumal Arumugam Desingu; Shruti M Kizkekra; Anwit Shriniwas Pandit; Shweta Kumar; Danish Khan; Sathees C Raghavan; Nagalingam R Sundaresan
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.